Sientra Inc
F:S0Z
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Sientra Inc
Total Liabilities & Equity
Sientra Inc
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Sientra Inc
F:S0Z
|
Total Liabilities & Equity
$139.9m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Haemonetics Corp
NYSE:HAE
|
Total Liabilities & Equity
$2.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
14%
|
CAGR 10-Years
6%
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Total Liabilities & Equity
$4.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
18%
|
CAGR 10-Years
21%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Total Liabilities & Equity
$6.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
18%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Total Liabilities & Equity
$2.2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
21%
|
CAGR 10-Years
25%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Total Liabilities & Equity
$2.7B
|
CAGR 3-Years
17%
|
CAGR 5-Years
10%
|
CAGR 10-Years
13%
|
|
Sientra Inc
Glance View
Sientra, Inc. operates as a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices. The company is headquartered in Santa Barbara, California and currently employs 319 full-time employees. The company went IPO on 2014-10-29. The firm's primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures. The firm sells its breast implants and breast tissue expanders, or breast products to plastic surgeons. Its breast implants are primarily used in elective procedures, which are generally performed on a cash-pay basis. Implant Texture provides texturing on the implant shell that is designed to reduce the incidence of malposition, rotation and capsular contracture. The firm also offers breast tissue expanders for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The firm's brands also include Platinum20, Sientra Smooth, Sientra Teardrop, Allox, Allox2, Anatomical Controlled, BIOCORNEUM, Curve, Luxe, Softspan, Silishield and AuraG.
See Also
What is Sientra Inc's Total Liabilities & Equity?
Total Liabilities & Equity
139.9m
USD
Based on the financial report for Sep 30, 2023, Sientra Inc's Total Liabilities & Equity amounts to 139.9m USD.
What is Sientra Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
-5%
Over the last year, the Total Liabilities & Equity growth was -16%. The average annual Total Liabilities & Equity growth rates for Sientra Inc have been -8% over the past three years , -5% over the past five years .